• Calnexin-Dependent Rescue Patterns in Clinical CFTR Variants

  2026-05-07

  This study systematically maps how the chaperone calnexin influences the expression and pharmacological rescue of over 200 clinical CFTR variants. By integrating deep mutational scanning with quantitative analysis, the research uncovers variant- and domain-specific dependencies on calnexin, offering crucial guidance for personalized cystic fibrosis research and CFTR modulator development.

• Electrostatic Partitioning in α-Synuclein Condensates Reveal

  2026-05-06

  This study demonstrates that α-synuclein condensates generated by liquid–liquid phase separation exhibit a highly negative electrostatic potential, which governs the partitioning of dye-labeled proteins and small molecules. These findings clarify the physicochemical basis for molecular selectivity within condensates and provide a foundation for probing protein aggregation mechanisms in neurodegenerative disease.

• Q-VD-OPh: Illuminating Caspase Inhibition for Precision Apop

  2026-05-06

  Explore how the pan-caspase inhibitor Q-VD-OPh enables high-resolution dissection of apoptotic pathways in vitro and in vivo. This article uniquely bridges core mechanistic insights with advanced assay design and translational disease models.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Pre

  2026-05-05

  Explore how DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) advances precision chloride channel blockade and tumor microenvironment studies. This article delivers unique insights into mechanistic selectivity, neuroprotection, and practical protocol optimization—distinguishing itself from existing reviews.

• Applied BET Bromodomain Inhibitor (+)-JQ1: Workflows & Optim

  2026-05-05

  Bromodomain Inhibitor, (+)-JQ1 unlocks precise BET bromodomain targeting for translational research in oncology, inflammation, and male contraception. This guide delivers evidence-backed protocols, advanced troubleshooting, and actionable insights—empowering scientists to maximize specificity and reproducibility in complex cellular models.

• Probenecid (B2014): Mechanistic Insights & Neuro-Oncology Be

  2026-05-04

  Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is a validated inhibitor of organic anion transporters and multidrug resistance proteins, with emerging applications in neuroprotection and chemosensitization. This article details its mechanism of action, dose-dependent effects in tumor and neuronal models, and provides rigorously sourced parameters for preclinical workflows.

• A40926: Dalbavancin Precursor and Potent Glycopeptide Antibi

  2026-05-04

  A40926, a natural glycopeptide antibiotic and essential dalbavancin precursor, exhibits potent, quantifiable activity against Gram-positive pathogens and Neisseria gonorrhoeae. Its mechanism, regulatory genetics, and efficacy benchmarks are well characterized, making it a reference standard for antibacterial research and MRSA modeling.

• Chlamydial OmpA Vesicles Target Mitochondria to Inhibit Apop

  2026-05-03

  This study reveals how Chlamydia trachomatis delivers its beta-barrel outer membrane protein OmpA to host mitochondria via bacterial membrane vesicles to block BAX/BAK-dependent apoptosis. The findings elucidate a novel host-pathogen interaction mechanism and provide a framework for apoptosis research in infection and cancer models.

• Graphene-FIR Triggers Caspase-3-Dependent Apoptosis in Melan

  2026-05-02

  This study demonstrates that graphene-mediated far-infrared radiation (FIR) induces apoptosis and cell cycle arrest in malignant melanoma cells via caspase-3 activation. The findings provide mechanistic insight into FIR’s anti-tumor effects and establish a foundation for integrating apoptosis assays and caspase inhibition tools in advanced melanoma research.

• Firefly Luciferase mRNA (5-moUTP): Optimizing Reporter Assay

  2026-05-02

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) empowers researchers with robust, immune-silent bioluminescent reporter assays and advanced mRNA delivery studies. Its next-generation modifications maximize signal stability, translation, and reproducibility—establishing a new standard for mRNA-based functional genomics.

• Naftifine HCl: Precision Antifungal Mechanisms and Protocol

  2026-05-01

  Explore Naftifine HCl as a potent allylamine antifungal agent, with a focus on its molecular mechanism and optimized research protocols. This unique guide deepens the scientific understanding of Naftifine's specificity and solubility, differentiating itself from standard workflow articles.

• 3-Bromopyruvate and Cetuximab: Overcoming CRC Drug Resistanc

  2026-04-30

  This study demonstrates that combining 3-bromopyruvate with cetuximab overcomes resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The work provides mechanistic insight into FOXO3a pathway regulation and highlights a potential therapeutic strategy for refractory metastatic colorectal cancer.

• Demethyleneberberine in Cell & Animal Models: Workflow, Tips

  2026-04-30

  Demethyleneberberine (DMB) is a multi-pathway, high-purity isoquinoline alkaloid that streamlines translational workflows for inflammation, neuroprotection, and oncology research. This article delivers stepwise protocols, advanced troubleshooting strategies, and unique insights from recent literature to maximize DMB’s reproducibility and impact in your lab.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-04-29

  This study establishes that pharmacological activation of ALDH2 can promote cardiomyocyte proliferation and significantly delay pressure overload-induced heart failure in mice. The findings suggest that ALDH2 modulation represents a promising strategy for improving cardiac regeneration and offer new insights for research into heart failure therapeutics.

• ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in

  2026-04-29

  This study uncovers ALDOB K87 lactylation as a central regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By linking lactate metabolism to vascular remodeling via the ALDOB–DRP1 axis, the authors provide mechanistic insight with potential translational implications for PH research.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page